Recipe for Health: Can Curry Cure Blood Cancers?
Researchers to further evaluate the potential benefits of natural compounds against certain cancers
Gerardo Mackenzie, PhD, Assistant Professor, Department of Preventive Medicine, and Stony Brook University Cancer Center
STONY BROOK, NY, MAY 22, 2014 – Gerardo Mackenzie, PhD, Assistant Professor, Department of Preventive Medicine, and Stony Brook University Cancer Center was awarded a $179,000 grant investigating the prevention of Hodgkin’s lymphoma. Recognizing Stony Brook Medicine’s expertise related to research in this area, the Jesse & Julie Rasch Foundation sponsored the grant.
“We are excited to be working with Dr. Mackenzie and the team at Stony Brook,” says Jesse Rasch, Chairman of the Rasch Foundation. “We believe that certain natural compounds have tremendous potential to both prevent and help treat blood cancers. Not enough is being done to evaluate these promising compounds, so we are delighted to help drive this research forward.”
Entitled “Evaluation of the anti-cancer effect of various compounds against Hodgkin’s lymphoma,” the study will evaluate the safety and efficacy of select test agents in preclinical models of Hodgkin’s lymphoma. Dr. Mackenzie and his team will study numerous compounds that have been linked to cancer prevention in general and prevention of Hodgkin’s lymphoma in particular.
A major focus of the research will be the evaluation of curcumin, one of the primary ingredients in turmeric and curry powders as well as various formulations of curcumin, specifically prepared to increase its bioavailability. Besides curcumin, other natural compounds being investigated include polyphenols, aspirin, vitamins, minerals, fish oils, probiotics and other agents known to boost the immune system. In preclinical models of Hodgkin’s lymphoma, they will look at toxicities related to dosage as well as each compound’s potential for reducing tumor growth. If this approach is found to be successful, the team hopes, in the near future, to translate these novel therapies into …